NTRK2 and Alzheimer disease: By activating TrkB, 7,8-DHF triggers downstream signaling cascades such as the PI3K/Akt, MAPK/ERK, and PLCγ pathways, thereby promoting neuronal survival, reducing apoptosis, and enhancing synaptic strength—processes that are severely compromised in AD [22].